Login    Join free Add to favorites    中文
home > news > 2nd Antibody-based Therapeutics and BioProduction Forum
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
2nd Antibody-based Therapeutics and BioProduction Forum

hits:312     Date:05/03/18

2nd Antibody-based Therapeutics and BioProduction Forum

Event Name: Antibody-based Therapeutics and BioProduction Forum
Event Date: Aug.29-31.2018
Event Venue: Shanghai, PR. China
Event website: www.abbforum.com
 
The Antibody and Antibody-based Therapeutics have entered the center stage of drug discovery and been reflected through the major shift of focus in pipeline by pharmaceutical companies from small molecules to a broader portfolio with biologics and chemical agents. Roughly, as of end of 2017, over 70 antibody therapeutics have been approved. Not only in Western Countries, there have been also considerable biologics R&D, manufacturing and commercial activities in Asia. In 2015, the China FDA also received the country's first biosimilar guidelines to establish the basic principles for development and technical evaluation of biosimilars towards the adoption of a more concrete and well-defined regulatory pathway.
 
In return, produced and organized by Deliver Life Sciences, and under support of SAPA-GP and SABPA, the 2nd Antibody-based Therapeutics and BioProduction Forum would invite over 60-70 domestic and international experts to build up and facilitate the communications and partnerships to accelerate Biologics R&D, Characterization and Production.
 
2018 Forum Main Discussions
Antibody-based Therapeutics Forum
-Recent trends and Development for Antibody Therapeutics
-The Development of Antibody Therapeutics in China
-ADC Development, Characterization and Production
-Bispecific Antibodies, Novel/Similar Antibody Therapeutics
-Innovative Platform for Antibody Discovery and Engineering
-Biologics Characterization Strategies
 
 BioProduction Forum
-Innovation in Biologics Manufacturing
-Integrated Strategies for Rapid, Low-cost Clinical Material Production
-Quality Control, cGMP Manufacturing and Externalization
-Biologics Formulation, Aggregation and Stability Studies
-Cell Line, Culture Engineering and Downstream Processing
-Continuous Processing, QbD/PAT and Single-use Systems
 
For more up-to-date speakers and abstracts, please check inside the program or visit http://www.abbforum.com/Speakers.asp
 
Forum Contact
In addition to delegation, this conference provides premier exhibition, poster display, oral presentation, workshop and guided 1-on-1 meetings.
 
For more information on speaking and exploring a variety of participation options, please contact:
 
Wei Zhang
Manager, Programs and Events
Organizing Committee
e| wzhang@deliver-consulting.com
t | 86.21.6034.0229
 
David Xu
Program Executive
Organizing Committee
t | 86.21.6131.5702
 
About the Producer
Deliver Life Sciences is a specialty producer and organizer of the conference, workshop, public training together with tailored solutions to serve the growing biomedical industry in Asia. Through looking into the current trends of regulation, scientific findings and cutting-edge technology and work with the leading associations, regulatory agencies, industry and academia KOLs, we translate, formulate and promote our offerings from basic medicinal research, discovery to development till commercialization.  For more information and our past events, please visit: www.diyi-consulting.com
Related News>> more
advertisement

Copyright(C) 2006-2018 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙